ABB Shareholders Approve All Proposals at Annual General Meeting
- Jennifer Xin-Zhe Li, Geraldine Matchett and Gunnar Brock elected as new me...
2018-04-03
文传商讯
Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizum
Efficacy and safety of afatinib plus pembrolizumab to be assessed in Phase I...
2017-02-10
文传商讯
Boehringer Ingelheim biosimilar candidate to Humira® accepted for E
• BI 695501 EMA and FDA applications are first biosimilar regulatory f...
2017-01-28
文传商讯
Clinically meaningful data for oral nintedanib in mesothelioma presente
Mesothelioma is a rare and difficult-to-treat cancer with no targeted treatm...
2016-12-09
文传商讯
LUME-Meso trial enrols first patient: Boehringer Ingelheim’s new pivot
The trial will evaluate efficacy and safety of nintedanib* as a first-line o...
2016-05-11
文传商讯
